Current and Future Perspectives in the Diagnosis and Management of Helicobacter pylori Infection

por Shatila, Malek, Thomas, Anusha Shirwaikar
Publicado 2022

Gastrointestinal lymphoma: the new mimic

por Shirwaikar Thomas, Anusha, Schwartz, Mary, Quigley, Eamonn
Publicado 2019

Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding in a Patient with a Left Ventricular Assist Device

por Thomas, Anusha Shirwaikar, Estep, Jerry, Victor, David W.
Publicado 2018

Implementing an immunotherapy toxicity (IOTOX) GI service improves outcomes in patients with immune-mediated diarrhea and colitis

por Saji, Alice, Chopra, Maneera, Jacob, Jake, Altan, Mehmet, Alhalabi, Omar, Shah, Amishi Yogesh, Qiao, Wei, Wang, Yinghong, Thomas, Anusha
Publicado 2022

Obesity Measured via Body Mass Index May Be Associated with Increased Incidence but Not Worse Outcomes of Immune-Mediated Diarrhea and Colitis

por Kono, Miho, Shatila, Malek, Xu, Guofan, Lu, Yang, Mathew, Antony, Mohajir, Wasay, Varatharajalu, Krishnavathana, Qiao, Wei, Thomas, Anusha S., Wang, Yinghong
Publicado 2023

Safety and efficacy of fecal microbiota transplantation to treat and prevent recurrent Clostridioides difficile in cancer patients

por Ali, Hiba, Khurana, Shruti, Ma, Weijie, Peng, Yuanzun, Jiang, Zhi-Dong, DuPont, Herbert, Zhang, Hao Chi, Thomas, Anusha S., Okhuysen, Pablo, Wang, Yinghong
Publicado 2021

Clinical Characteristics and Outcomes of Patients with Positive Celiac Serology and Cancer Therapy Exposure

por Dutra, Barbara Erthal Smeral, Wei, Dongguang, Tan, Dongfeng, Alasadi, Mazen, Zhang, Hao Chi, Thomas, Austin, Thomas, Anusha Shirwaikar, Richards, David Matthew, Wang, Yinghong
Publicado 2022

Clostridioides difficile infection in cancer patients receiving immune checkpoint inhibitors

por Vasavada, Shaleen, Panneerselvam, Kavea, Amin, Rajan, Varatharajalu, Krishnavathana, Okhuysen, Pablo C., Oliva, Isabella C. Glitza, Wang, Jianbo, Grivas, Petros, Thomas, Anusha S., Wang, Yinghong
Publicado 2022

Immune checkpoint inhibitor-related gastrointestinal toxicity in patients with malignancy involving the luminal gastrointestinal tract and its impact on cancer outcomes

por Yu, Kevin, Mathew, Antony, Abraham, Fiyinfoluwa, Amin, Rajan, Kono, Miho, Overman, Michael, Zhao, Dan, Khan, Anam, Khan, Muhammad A., Thomas, Anusha S., Wang, Yinghong
Publicado 2022

Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis

por Zou, Fangwen, Wang, Xuemei, Glitza Oliva, Isabella C, McQuade, Jennifer L, Wang, Jennifer, Zhang, Hao Chi, Thompson, John A, Thomas, Anusha S, Wang, Yinghong
Publicado 2021

Cytomegalovirus infection among patients with cancer receiving immune checkpoint inhibitors

por Panneerselvam, Kavea, Szafron, David, Amin, Rajan N., Wei, Dongguang, Tan, Dongfeng, Altan, Mehmet, Okhuysen, Pablo C., Shatila, Malek, Raju, Gottumukkala Subba, Thomas, Anusha S., Wang, Yinghong
Publicado 2022

Diarrhea and colitis related to immune checkpoint inhibitor and BRAF/MEK inhibitor therapy

por Kuang, Andrew G., Mohajir, Wasay, Panneerselvam, Kavea, McQuade, Jennifer L., Oliva, Isabella C. Glitz, Khan, Muhammad Ali, Zhang, Hao Chi, Thomas, Anusha S., Wang, Yinghong
Publicado 2023

Clinical Features and Management of Acute and Chronic Radiation-Induced Colitis and Proctopathy

por Abu-Sbeih, Hamzah, Tang, Tenglong, Ali, Faisal S., Ma, Weijie, Shatila, Malek, Luo, Wenyi, Tan, Dongfeng, Tang, Chad, Richards, David M., Ge, Phillip S., Thomas, Anusha S., Wang, Yinghong
Publicado 2023

The Safety of Immunosuppressants Used in the Treatment of Immune-Related Adverse Events due to Immune Checkpoint Inhibitors: a Systematic Review

por Machado, Antonio Pizuorno, Ratliff, Hunter, Abdelwahab, Ahmed, Vohra, Muhammad H., Kuang, Andrew, Shatila, Malek, Khan, Muhammad Ali, Shafi, Menhaz A., Thomas, Anusha S., Philpott, Jessica, Alhalabi, Omar, Wang, Yinghong
Publicado 2023

Role of C-Reactive Protein in Predicting the Severity and Response of Immune-Mediated Diarrhea and Colitis in Patients with Cancer

por Liu, Cynthia, Shatila, Malek, Mathew, Antony, Machado, Antonio Pizuorno, Thomas, Austin, Zhang, Hao Chi, Thomas, Anusha S., Faleck, David, Funchain, Pauline, Philpott, Jessica, Grivas, Petros, Obeid, Michel, Carbonnel, Franck, Wang, Yinghong
Publicado 2023

Colon Adenoma After Diagnosis of Immune Checkpoint Inhibitor-mediated Colitis

por Machado, Antonio Pizuorno, Shatila, Malek, De Toni, Enrico N., Török, Helga-Paula, Philpott, Jessica, Zhao, Dan, Zhou, Yan, Varatharajalu, Krishnavathana, Shafi, Mehnaz A., Zhang, Hao Chi, Thomas, Anusha S., Wang, Yinghong
Publicado 2023

Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study

por Zou, Fangwen, Faleck, David, Thomas, Anusha, Harris, Jessica, Satish, Deepika, Wang, Xuemei, Charabaty, Aline, Ernstoff, Marc S, Glitza Oliva, Isabella C, Hanauer, Stephen, McQuade, Jennifer, Obeid, Michel, Shah, Amishi, Richards, David M, Sharon, Elad, Wolchok, Jedd, Thompson, John, Wang, Yinghong
Publicado 2021

Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis

por Badran, Yousef R, Zou, Fangwen, Durbin, Sienna M, Dutra, Barbara E, Abu-Sbeih, Hamzah, Thomas, Anusha S, Altan, Mehmet, Thompson, John A, Qiao, Wei, Leet, Donna E, Lai, Po-Ying, Horick, Nora K, Postow, Michael A, Faleck, David M, Wang, Yinghong, Dougan, Michael
Publicado 2023